Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
48,324,727
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
1,978,698
-
Shares change
-
-609,761
-
Total reported value, excl. options
-
$606,612
-
Value change
-
-$1,718,334
-
Number of buys
-
17
-
Number of sells
-
6
-
Price
-
$0.3070
Institutional Holders of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) as of Q2 2025
As of 30 Jun 2025 INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) had 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,978,698 shares of stock of the company.
Largest 10 holders included SAPIENT CAPITAL LLC, Sentinus, LLC, BROWN ADVISORY INC, Mesirow Financial Investment Management, Inc., GEODE CAPITAL MANAGEMENT, LLC, Sigma Planning Corp, Warberg Asset Management LLC, JANE STREET GROUP, LLC, VANGUARD GROUP INC, and BLAIR WILLIAM & CO/IL.
This table shows 27 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.